| 000 | 01595 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514021259.0 | ||
| 264 | 0 | _c20020313 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a0889-8553 | ||
| 024 | 7 |
_a10.1016/s0889-8553(05)70224-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKrishnan, K | |
| 245 | 0 | 0 |
_aProstaglandin inhibitors and the chemoprevention of noncolonic malignancy. _h[electronic resource] |
| 260 |
_bGastroenterology clinics of North America _cDec 2001 |
||
| 300 |
_a981-1000 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xphysiopathology |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
| 650 | 0 | 4 |
_aBarrett Esophagus _xphysiopathology |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xphysiopathology |
| 650 | 0 | 4 | _aCyclooxygenase 2 |
| 650 | 0 | 4 | _aCyclooxygenase 2 Inhibitors |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xphysiopathology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoenzymes _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMembrane Proteins |
| 650 | 0 | 4 |
_aProstaglandin Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aProstaglandin-Endoperoxide Synthases |
| 650 | 0 | 4 |
_aStomach Neoplasms _xphysiopathology |
| 700 | 1 | _aBrenner, D E | |
| 773 | 0 |
_tGastroenterology clinics of North America _gvol. 30 _gno. 4 _gp. 981-1000 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0889-8553(05)70224-7 _zAvailable from publisher's website |
| 999 |
_c11676653 _d11676653 |
||